Nicholas Investment Partners’s Immunovant IMVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
2024
Q3
$944K Buy
2024
Q2
Sell
2024
Q1
$4.45M Buy
2023
Q4
$5.74M Sell
2023
Q3
$14.5M Buy